Tumor Board

A tumor board is a regular meeting of cancer specialists from different fields (including surgeons, medical oncologists, radiation oncologists, pathologists, and radiologists) who review individual patient cases together and recommend a coordinated treatment plan. For complex cancers like mesothelioma, a multidisciplinary tumor board is considered the standard way to decide on the best combination of surgery, chemotherapy, immunotherapy, and radiation.

Origin

The concept emerged in U.S. cancer centers in the mid-20th century as oncology became more specialized and it grew clear that single-physician decisions were inadequate for complex cancers. The Commission on Cancer (a program of the American College of Surgeons) helped standardize multidisciplinary tumor board requirements at accredited cancer programs beginning in the 1980s and 1990s.

Significance in Asbestos Context

Mesothelioma is rare, biologically aggressive, and treated very differently depending on cell type, stage, and patient fitness, which is why presentation at a mesothelioma-experienced tumor board can meaningfully change a patient's treatment plan and prognosis. Many community oncologists see only a handful of mesothelioma cases in a career, so a tumor board at a high-volume center can identify options such as cytoreductive surgery, HIPEC, pleurectomy/decortication, extrapleural pneumonectomy, or clinical trials of immunotherapy that might otherwise be missed. The tumor board's written recommendation also becomes part of the medical record and can serve as important documentation in a legal claim, showing the diagnosis was confirmed and that treatment decisions were made by recognized experts.

Example Sentence

After her pleural mesothelioma diagnosis, the patient asked to be referred to a comprehensive cancer center so her case could be reviewed by a tumor board with mesothelioma experience before starting chemotherapy.

Related Terms

Multidisciplinary Care, Mesothelioma, Pathology Review, Clinical Trial, Pleurectomy/Decortication, Second Opinion

Notes

• Ask your oncologist directly: "Will my case be presented at a tumor board, and is there a mesothelioma specialist on that board?" If not, request a referral to a center that holds one. Major mesothelioma programs include those at MD Anderson, Memorial Sloan Kettering, Brigham and Women's, Penn, UCLA, and the University of Chicago, among others.
• Request a copy of the tumor board's written recommendation for your medical records; it documents the diagnosis, staging, and treatment rationale, all of which may be relevant to a legal claim.
• Before the tumor board meets, make sure your pathology slides have been re-reviewed by a mesothelioma-experienced pathologist, because misdiagnosis (especially confusing mesothelioma with adenocarcinoma) is common and changes the entire treatment plan.
• A tumor board recommendation is not binding. You can still seek a second opinion or decline a recommended treatment, and you should ask the team to explain alternatives, including clinical trials.